PubMed:28068934 / 131-255 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T2","span":{"begin":0,"end":124},"obj":"Sentence"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}

{"project":"LitCoin-entities","denotations":[{"id":"12039","span":{"begin":12,"end":18},"obj":"GeneOrGeneProduct"},{"id":"12040","span":{"begin":82,"end":116},"obj":"DiseaseOrPhenotypicFeature"},{"id":"12041","span":{"begin":118,"end":122},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"db_id","subj":"12039","obj":"NCBIGene:5290"},{"id":"A4","pred":"db_id","subj":"12040","obj":"MESH:D000077277"},{"id":"A5","pred":"db_id","subj":"12041","obj":"MESH:D000077277"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T4","span":{"begin":82,"end":116},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":93,"end":116},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T6","span":{"begin":107,"end":116},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"0005580"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"0005096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"0004993"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T4","span":{"begin":12,"end":18},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":19,"end":28},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":102,"end":106},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":118,"end":122},"obj":"GeneOrGeneProduct"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T3","span":{"begin":12,"end":18},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":102,"end":106},"obj":"GeneOrGeneProduct"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T2","span":{"begin":82,"end":116},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":118,"end":122},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"originalLabel","subj":"T2","obj":"D000077277"},{"id":"A3","pred":"originalLabel","subj":"T3","obj":"D000077277"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T2","span":{"begin":12,"end":18},"obj":"GeneOrGeneProduct"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T2","span":{"begin":82,"end":116},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":118,"end":122},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0005580"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0005580"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T2","span":{"begin":82,"end":116},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":118,"end":122},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"ID:","subj":"T2","obj":"D000077277"},{"id":"A3","pred":"ID:","subj":"T3","obj":"D000077277"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T2","span":{"begin":82,"end":116},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":118,"end":122},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"#label","subj":"T2","obj":"D000077277"},{"id":"A3","pred":"#label","subj":"T3","obj":"D000077277"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T47772","span":{"begin":12,"end":18},"obj":"GeneOrGeneProduct"},{"id":"T79411","span":{"begin":118,"end":122},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T15688","span":{"begin":82,"end":116},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A73973","pred":"#label","subj":"T79411","obj":"D000077277"},{"id":"A32749","pred":"#label","subj":"T15688","obj":"D000077277"}],"text":"BACKGROUND: PIK3CA mutations are expected to be potential therapeutic targets for esophageal squamous cell carcinoma (ESCC)."}